Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States

Journal article

Open access

Peer reviewed

Mickaël Hiligsmann, Stuart S. Silverman, Andrea J. Singer, Leny Pearman, Jake Mathew, Yamei Wang, John Caminis and Jean-Yves Reginster

PharmacoEconomics, Vol.41(7), pp.819-830

01/07/2023

PMID: 37086385

Abstract

Original

url

https://doi.org/10.1007/s40273-023-01270-xView

Published (Version of record) Open

1 Record Views

Title: Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States
Creators - without role: Mickaël Hiligsmann - Maastricht University
Stuart S. Silverman - Cedars-Sinai Medical Center
Andrea J. Singer - MedStar Georgetown University Hospital
Leny Pearman - Radius Health
Jake Mathew - Radius Health
Yamei Wang - Radius Health
John Caminis - Radius Health
Jean-Yves Reginster - University of Liège
Publication Details: PharmacoEconomics, Vol.41(7), pp.819-830
Publisher: Springer International Publishing
Grant note: ;
Identifiers: 9947904208331
Academic Unit: King Saud University
Language: English
Resource Type: Journal article